DE60000203D1 - Protein:prenyl Transferase Inhibitoren - Google Patents

Protein:prenyl Transferase Inhibitoren

Info

Publication number
DE60000203D1
DE60000203D1 DE60000203T DE60000203T DE60000203D1 DE 60000203 D1 DE60000203 D1 DE 60000203D1 DE 60000203 T DE60000203 T DE 60000203T DE 60000203 T DE60000203 T DE 60000203T DE 60000203 D1 DE60000203 D1 DE 60000203D1
Authority
DE
Germany
Prior art keywords
hydrogen
alkyl
protein
transferase inhibitors
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60000203T
Other languages
English (en)
Other versions
DE60000203T2 (de
Inventor
Herman Steven Overkleeft
Steven Hendrik Leonar Verhelst
Nicolaas Johannes Meeuwenoord
Elsbet Jantine Pieterman
Louis Hartog Cohen
Mark Overhand
Der Marel Gijsbert Arie Van
Boom Jocobus Hubertus Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Universiteit Leiden
Original Assignee
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO, Universiteit Leiden filed Critical Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Publication of DE60000203D1 publication Critical patent/DE60000203D1/de
Application granted granted Critical
Publication of DE60000203T2 publication Critical patent/DE60000203T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyrane Compounds (AREA)
DE60000203T 1999-02-03 2000-02-03 Protein:prenyl Transferase Inhibitoren Expired - Fee Related DE60000203T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200316 1999-02-03

Publications (2)

Publication Number Publication Date
DE60000203D1 true DE60000203D1 (de) 2002-07-18
DE60000203T2 DE60000203T2 (de) 2003-02-06

Family

ID=8239861

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60000203T Expired - Fee Related DE60000203T2 (de) 1999-02-03 2000-02-03 Protein:prenyl Transferase Inhibitoren

Country Status (7)

Country Link
US (1) US6376468B1 (de)
EP (1) EP1028117B1 (de)
JP (1) JP2000226383A (de)
AT (1) ATE219072T1 (de)
DE (1) DE60000203T2 (de)
DK (1) DK1028117T3 (de)
ES (1) ES2174794T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056947B2 (en) * 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
US8013014B2 (en) * 2002-07-05 2011-09-06 Georgia Tech Research Corporation Aza-peptide epoxides
EP1723124A1 (de) * 2004-02-18 2006-11-22 Georgia Tech Research Corporation Propenoylhydrazide
US20060014939A1 (en) * 2004-07-15 2006-01-19 Chakraborty Tushar K Novel C6-substituted furanoid sugar amino acids and improved process for preparing the same
US20090183503A1 (en) * 2008-01-18 2009-07-23 Alberto Verdesi Exhaust apparatus
WO2009148709A1 (en) * 2008-04-16 2009-12-10 University Of Utah Research Foundation Pharmacological targeting of vascular malformations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors

Also Published As

Publication number Publication date
ES2174794T3 (es) 2002-11-16
EP1028117B1 (de) 2002-06-12
ATE219072T1 (de) 2002-06-15
EP1028117A3 (de) 2000-08-23
EP1028117A2 (de) 2000-08-16
US6376468B1 (en) 2002-04-23
JP2000226383A (ja) 2000-08-15
DK1028117T3 (da) 2002-09-16
DE60000203T2 (de) 2003-02-06

Similar Documents

Publication Publication Date Title
MXPA02002720A (es) Nuevos compuestos de alfa-aminoacido-sulfonilo, un proceso para su preparacion y composiciones farmaceuticas que los comprenden.
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
BR9508187A (pt) Produtos e composição farmacêutica
CO5700773A2 (es) Derivados de bencimidazol
HUP0002942A2 (hu) Szerin proteáz inhibitor hatású peptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
ATE114670T1 (de) Phenylamidinderivate als plättchenaggregationsinhibitoren.
DE60327550D1 (de) Substituierte indoloxoacetylaminoessigsäurederivate als inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
DK1265606T3 (da) Celleadhæsionsinhibitorer
HK1050324A1 (en) Stabilized pharmaceutical composition containing the calcium channel blocker azelnidipine
AR024364A1 (es) Una composicion cosmetica para el adelgazamiento a base l-arginina, de un analogo de l-arginina, o de uno de sus derivados, que se administra por viatopica
AR029145A1 (es) Compuesto de hidroxamato pirrolidina sustituida, inhibidores de metaloproteasa, composicion farmaceutica que lo comprende y uso para elaborar una composicion farmaceutica
UY25986A1 (es) Complejo del inhibidor de ras-farnesiltransferasa y sulfobutiléter-7-beta-ciclodextrina o 2-hidroxipropil-beta-ciclodextrina y método.
DE60000203T2 (de) Protein:prenyl Transferase Inhibitoren
NZ242108A (en) Azadecalin amides and thioamides, and pharmaceutical compositions
RU2008151775A (ru) Способы сайт-специфического пегилирования
WO2004026896A3 (en) Hcv ns-3 serine protease inhibitors
ATE380172T1 (de) Benzylaminanalogen
DE69415314D1 (de) Neue bisoxadiazolidinderivate
DE69940551D1 (de) Mercaptane und disulfide
DK640489D0 (da) C63-amidderivater af 34-de-(acetylglucosaminyl)-34-deoxy-teicoplaniner
DK0540782T3 (da) Anvendelse af polyisoprenylpyrophosphatanaloger til inhibering af proteinisoprenylering
BR0107204A (pt) Inibidores da angiogênese de hidrazida e alcoxiamida
WO2002020566A3 (de) NEUE MMP-2-DERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿3?
AR012697A1 (es) Metodo para controlar el crecimiento de malezas en un lugar; compuestos de 5-ciclopropil-4-[4-fluor-3-metoxi-2-metoxisulfonil, sulfinil o sulfinil-benzoil]-isoxazol o 2-ciano-3-ciclopropil-1-fenil-propan-1,3-diona, de aplicacion en dicho metodo; composiciones herbicidas formuladas con dichos
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee